Abbonarsi

Diastolic dysfunction after mediastinal irradiation - 21/08/11

Doi : 10.1016/j.ahj.2004.12.026 
Paul A. Heidenreich, MD a, b, , Steven L. Hancock, MD c, Randall H. Vagelos, MD b, Byron K. Lee, MD d, Ingela Schnittger, MD b
 Cardiology Section, VA Palo Alto Health Care System, Stanford University, Stanford, Calif 
b Department of Medicine, Stanford University, Stanford, Calif 
c Department of Radiation Oncology, Stanford University, Stanford, Calif 
d Department of Medicine, University of California at San Francisco, San Francisco, Calif 

Reprint requests: Paul A. Heidenreich, MD, 111C Cardiology, Palo Alto VA Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94034.

Riassunto

Background

Mediastinal irradiation is known to cause cardiac disease, but its effect on left ventricular diastolic function is unknown. The purpose of this study was to determine the prevalence of diastolic dysfunction and its association with prognosis in asymptomatic patients after mediastinal irradiation.

Methods

We recruited 294 patients who had received at least 35 Gy to the mediastinum for treatment of Hodgkin disease. Each patient underwent resting echocardiography, stress echocardiography, and nuclear scintigraphy. Survival free from cardiac events was determined during 3.2 years of follow-up.

Results

The mean age of the included patients was 42 years, and 49% were male. Adequate measurements of diastolic function were obtained in 282 (97%) patients. Diastolic dysfunction was considered mild in 26 (9%) and moderate in 14 (5%). Exercise-induced ischemia was more common in patients with diastolic dysfunction (23%) than those with normal diastolic function (11%, P = .008). After adjustment for patient demographics, clinical characteristics, and radiation history, patients with diastolic dysfunction had worse event-free survival than patients with normal function (hazard ratio 1.66, 95% CI 1.06-2.4).

Conclusions

There is a high prevalence of diastolic dysfunction in asymptomatic patients after mediastinal irradiation, and the presence of diastolic dysfunction is associated with stress-induced ischemia and a worse prognosis. Screening with Doppler echocardiography may be helpful in identifying patients at risk for subsequent cardiac events.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 The study was supported by grant 1 RO1 CA 63001 from the National Cancer Institute, National Institutes of Health. PAH is supported by a Career Development Award from the Veteran's Affairs Health Services Research Development Office.


© 2005  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 150 - N° 5

P. 977-982 - novembre 2005 Ritorno al numero
Articolo precedente Articolo precedente
  • Racial differences in outcome and treatment effect in congestive heart failure
  • James Mathew, Janet Wittes, Frances McSherry, William Williford, Rekha Garg, Jeffrey Probstfield, Salim Yusuf, Digitalis Investigation Group
| Articolo seguente Articolo seguente
  • Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure
  • Femida H. Gwadry-Sridhar, J. Malcolm O. Arnold, Ying Zhang, James E. Brown, Gordon Marchiori, Gordon Guyatt

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.